Pnc Financial Services Group, Inc. Altimmune, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $162 Billion
- Q3 2025
A detailed history of Pnc Financial Services Group, Inc. transactions in Altimmune, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 2,881 shares of ALT stock, worth $12,013. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,881
Previous 1,689
70.57%
Holding current value
$12,013
Previous $6,000
66.67%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding ALT
# of Institutions
194Shares Held
40.1MCall Options Held
3.82MPut Options Held
2.8M-
Vanguard Group Inc Valley Forge, PA6.37MShares$26.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.32MShares$22.2 Million0.0% of portfolio
-
State Street Corp Boston, MA3.6MShares$15 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.13MShares$8.89 Million0.37% of portfolio
-
Geode Capital Management, LLC Boston, MA2.02MShares$8.41 Million0.0% of portfolio
About Altimmune, Inc.
- Ticker ALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,025,300
- Market Cap $204M
- Description
- Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...